1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An integrative genomics approach uncovers the basis of resistance to AZA therapy in MDS and CMML
    Meeting Abstract

    Unnikrishnan, A.; Papaemmanuil, E.; Beck, D.; Verma, A.; Kumari, A.; Richards, L. A.; Knezevic, K.; Chandrakanthan, V.; Thoms, J. A. I.; Tursky, M. L.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • From T-cell engineering to CAR therapy: Progress and prospects
    Meeting Abstract

    Sadelain, M.
    Blood (2015)

    Fulltext@MSK | Save
  • Recurrent mutations in CCND3 confer clinical resistance to FLT3 inhibitors
    Meeting Abstract

    Smith, C. C.; Viny, A. D.; Massi, E. S.; Kandoth, C.; Socci, N. D.; Hsu, H.; West, B.; Bollag, G.; Taylor, B. S.; Levine, R. L.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Safety and efficacy of AG-221, a potent inhibitor of mutant IDH2 that promotes differentiation of myeloid cells in patients with advanced hematologic malignancies: Results of a phase 1/2 trial
    Meeting Abstract

    Stein, E. M.; DiNardo, C.; Altman, J. K.; Collins, R.; DeAngelo, D. J.; Kantarjian, H. M.; Sekeres, M. A.; Fathi, A. T.; Flinn, I. W.; Frankel, A. E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Targeting the Hsp90 oncoproteome in Burkitt lymphoma
    Meeting Abstract

    Roth, L. G.; van Besien, H.; Rodina, A.; Taldone, T.; Erdjument-Bromage, H.; Barth, M. J.; Chiosis, G.; Cesarman, E.
    Blood (2015)

    Fulltext@MSK | Save
  • Integrated DNA/RNA profiling for somatic alterations in adult B-cell ALL
    Meeting Abstract

    Rapaport, F.; Patel, J.; He, J.; Brennan, T. A.; Nahas, M.; Balassubramanian, S.; Otto, G.; Lipson, D.; Stephens, P.; Miller, V. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Clincial and genetic landscapes differ between IGH-CRLF2 and P2RY8-CRLF2 acute lymphoblastic leukaemia
    Meeting Abstract

    Russell, L. J.; Jones, L.; Enshaei, A.; Rutherford, J.; Tonin, S.; Ryan, S.; Eswaran, J.; Papaemmanuil, E.; Tubio, J.; Campbell, P. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Integrative genome-wide analysis of RNA binding and splicing reveals complex loss and gain of function alterations by SRSF2 P95 mutations in myelodysplasia
    Meeting Abstract

    Rejeski, K.; Liang, Y.; Tebaldi, T.; Stefani, G.; Taylor, A.; Maziarz, J.; Song, Y. B.; Balasubramanian, K.; Vasic, R.; Kapetanovic, E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Implications of minimal residual disease negative complete remission (MRD-CR) and allogeneic stem cell transplant on safety and clinical outcome of CD19 targeted 19-28z CAR modified T cells in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Wang, Y.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • IKZF2, a novel target of MSI2 RNA-binding protein plays an oncogenic role in myeloid leukemia
    Meeting Abstract

    Park, S. M.; Thornton, A.; Vu, L. P.; Chhangawala, S.; Minuesa, G.; Barlowe, T.; Taggart, J.; Tivnan, P.; Kim, T.; Shevach, E.; more...
    Blood (2015)

    Fulltext@MSK | Save